Verseon Corporation Additional Listing & Total Voting Rights (7969D)
02 May 2017 - 4:01PM
UK Regulatory
TIDMVSN
RNS Number : 7969D
Verseon Corporation
02 May 2017
May 2, 2017
Verseon Corporation
("Verseon" or the "Company")
Additional Listing & Total Voting Rights
Verseon, a technology-based pharmaceutical company, announces
that application has been made for 19,117 new Common Shares of par
value $0.001 each (the "Common Shares") to be admitted to trading
on AIM pursuant to regularly scheduled vesting of the restricted
stock units (the "Issuance"). The Issuance is in connection with
the Verseon Corporation 2015 Equity Incentive Plan and pursuant to
the regularly scheduled vesting of previously granted restricted
stock units.
Of the 19,117 Common Shares issued, 7,010 Common Shares have
been issued to Dr. Thomas Hecht, Non-Executive Chairman of the
Company, in relation to payment of his Director's fees in the form
of restricted stock as has been previously disclosed, totalling
28,037 Common Shares vesting quarterly in equal proportions over a
one year period. Following Admission, Dr. Hecht will hold 45,328
Common Shares, representing 0.030% of the Company's issued share
capital.
Of the 19,117 Common Shares issued, 7,732 Common Shares have
been issued to Grover Wickersham, Non-Executive Director of the
Company, in relation to payment of his Director's fees in the form
of restricted stock as has been previously disclosed, totalling
15,463 Common Shares vesting quarterly in equal proportions over a
6 month period. Following Admission, Mr. Wickersham will hold
15,463 Common Shares, representing 0.010% of the Company's issued
share capital
The 19,117 new Common Shares issued pursuant to the Issuance
will rank pari passu with the Company's existing Common Shares and
admission to trading on AIM is expected to take place on 5 May 2017
("Admission").
Total Voting Rights
Following Admission, the issued share capital of the Company
will consist of 151,452,891 Common Shares. The Company does not
hold any shares in treasury. Therefore the total number of Common
Shares in the Company with voting rights will be 151,452,891. This
figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the FCA's
Disclosure and Transparency Rules.
For further information, please contact
Verseon Corporation www.verseon.com
+1 (510) 225
Tina Schlafly 9000
Cenkos Securities (NOMAD and
Joint Broker)
+44 (0) 20
Neil McDonald / Beth McKiernan 7397 8900
Cantor Fitzgerald Europe (Joint
Broker)
Marc Milmo / Phil Davies / +44 (0) 20
Callum Butterfield 7894 7000
Mirabaud Securities LLP (Joint
Broker)
+44 (0) 20
Peter Krens 7321 2508
For financial and business media enquiries, please contact
Buchanan Communications Ltd
(PR Advisers)
Henry Harrison-Topham / Jamie +44 (0) 20
Hooper 7466 5000
For trade and pharma media enquiries, please contact
Vane Percy & Roberts
+44 (0) 1737
Simon Vane Percy 821 890
1 Details of the person discharging managerial
responsibilities / person closely associated
---- --------------------------------------------------------
a) Name Dr. Thomas Hecht
---- -------------------------- ----------------------------
2 Reason for the notification
---- --------------------------------------------------------
a) Position/status Non-Executive Chairman
---- -------------------------- ----------------------------
b) Initial notification Initial notification
/Amendment
---- -------------------------- ----------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- --------------------------------------------------------
a) Name Verseon Corporation
---- -------------------------- ----------------------------
b) LEI N/a
---- -------------------------- ----------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- --------------------------------------------------------
a) Description of Restricted stock grant of
the financial Common Shares of par value
instrument, type $0.001
of instrument
Identification ISIN: USU9221J1098
code
---- -------------------------- ----------------------------
b) Nature of the Vesting of restricted stock
transaction units
---- -------------------------- ----------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
- 7,010
---------- ----------
---- -------------------------- ----------------------------
Aggregated information
- Aggregated volume 7,010
d) - Price -
---- -------------------------- ----------------------------
e) Date of the transaction 29 April 2017
---- -------------------------- ----------------------------
f) Place of the transaction N/a
---- -------------------------- ----------------------------
1 Details of the person discharging managerial
responsibilities / person closely associated
---- --------------------------------------------------------
a) Name Mr Grover Wickersham
---- -------------------------- ----------------------------
2 Reason for the notification
---- --------------------------------------------------------
a) Position/status Non-Executive Chairman
---- -------------------------- ----------------------------
b) Initial notification Initial notification
/Amendment
---- -------------------------- ----------------------------
3 Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
---- --------------------------------------------------------
a) Name Verseon Corporation
---- -------------------------- ----------------------------
b) LEI N/a
---- -------------------------- ----------------------------
4 Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
---- --------------------------------------------------------
a) Description of Restricted stock grant of
the financial Common Shares of par value
instrument, type $0.001
of instrument
Identification ISIN: USU9221J1098
code
---- -------------------------- ----------------------------
b) Nature of the Vesting of restricted stock
transaction units
---- -------------------------- ----------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
---------- ----------
- 7,732
---------- ----------
---- -------------------------- ----------------------------
Aggregated information
- Aggregated volume 7,732
d) - Price -
---- -------------------------- ----------------------------
e) Date of the transaction 29 April 2017
---- -------------------------- ----------------------------
f) Place of the transaction N/a
---- -------------------------- ----------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEALSFEDDXEFF
(END) Dow Jones Newswires
May 02, 2017 02:01 ET (06:01 GMT)
Verseon (LSE:VSN)
Historical Stock Chart
From Apr 2024 to May 2024
Verseon (LSE:VSN)
Historical Stock Chart
From May 2023 to May 2024